Body Composition, IGF1 Status, and Physical Functionality in Nonagenarians: Implications for Osteosarcopenia.
Body Composition, IGF1 Status, and Physical Functionality in Nonagenarians: Implications for Osteosarcopenia.
复制标题
DOI:
10.1016/j.jamda.2018.07.007
复制
发表时间:
2019-01
影响因子:
7.6
通讯作者:
Ravussin E
中科院分区:
文献类型:
--
作者:
Poggiogalle E;Cherry KE;Su LJ;Kim S;Myers L;Welsh DA;Jazwinski SM;Ravussin E
Body composition alterations occur during aging. The purpose of the present analysis was to explore the functional consequences of the overlap of sarcopenia and osteoporosis, and the potential role of insulin-like growth factor 1 (IGF1) in their development in the oldest old. Eighty-seven nonagenarians from the Louisiana Healthy Aging Study were included. The definition of sarcopenia was based on appendicular lean mass (ALM). Osteoporosis was diagnosed based on bone mineral density (BMD) T score. Four phenotypes were compared: (1) healthy body composition, that is, nonosteoporotic nonsarcopenic (CO, control group), (2) osteoporotic (O, low BMD T score), (3) sarcopenic (S, low ALM), and (4) osteosarcopenic (OS, low BMD T score and low ALM). Sex- and age-specific IGF1-Standard Deviation Scores (SDS) were calculated. The Continuous Scalee Physical Functional Performance (CS-PFP) test was performed. In OS men, IGF1-SDS values (−0.61 ±0.37 vs −0.04 ± 0.52, P = .02) were lower than those in CO males (control group), whereas IGF1-SDS were similar in the 4 body composition phenotypes in women. In men only, ALM was positively associated with IGF1-SDS values (P = .01) independent of age and C-reactive protein concentration. Regarding bone health, we found no association between IGF1-SDS values and BMD. IGF1-SDS was not associated with functional performance (CS-PFP) in men and women. IGF1 sensitivity in skeletal muscle and bone may differ by sex in the oldest old. IGF1 status did not appear to affect physical functionality. Determinants and clinical and functional characteristics of osteosarcopenia need to be further investigated in order to define conclusive diagnostic criteria.
登录
查看更多内容
DOI:
10.1093/gerona/glu023
发表时间:
2014-05-01
影响因子:
5.1
作者:
Cawthon, Peggy M.;Peters, Katherine W.;Alley, Dawn E.
通讯作者:
Alley, Dawn E.
影响因子:
39.2
作者:
Papadakis, MA;Grady, D;Grunfeld, C
通讯作者:
Grunfeld, C
影响因子:
4.6
作者:
Lu YC;Lin YC;Lin YK;Liu YJ;Chang KH;Chieng PU;Chan WP
通讯作者:
Chan WP
影响因子:
3.2
作者:
Cress, ME;Meyer, M
通讯作者:
Meyer, M
DOI:
10.1093/gerona/62.7.783
发表时间:
2007-07-01
影响因子:
5.1
作者:
Frisard, Madlyn I.;Fabre, Jennifer M.;Ravussin, Eric
通讯作者:
Ravussin, Eric